BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 26850064)

  • 1. Perioperative management and oncological outcomes following radical cystectomy for bladder cancer: a matched retrospective cohort study.
    Weingarten TN; Taccolini AM; Ahle ST; Dietz KR; Dowd SS; Frank I; Boorjian SA; Thapa P; Hanson AC; Schroeder DR; Sprung J
    Can J Anaesth; 2016 May; 63(5):584-95. PubMed ID: 26850064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peri-operative allogeneic blood transfusion does not adversely affect oncological outcomes after radical cystectomy for urinary bladder cancer: a propensity score-weighted European multicentre study.
    Vetterlein MW; Gild P; Kluth LA; Seisen T; Gierth M; Fritsche HM; Burger M; Protzel C; Hakenberg OW; von Landenberg N; Roghmann F; Noldus J; Nuhn P; Pycha A; Rink M; Chun FK; May M; Fisch M; Aziz A;
    BJU Int; 2018 Jan; 121(1):101-110. PubMed ID: 28905486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of peri-operative blood transfusion on the outcomes of patients undergoing radical cystectomy for urothelial carcinoma of the bladder.
    Kluth LA; Xylinas E; Rieken M; El Ghouayel M; Sun M; Karakiewicz PI; Lotan Y; Chun FK; Boorjian SA; Lee RK; Briganti A; RouprĂȘt M; Fisch M; Scherr DS; Shariat SF
    BJU Int; 2014 Mar; 113(3):393-8. PubMed ID: 24053618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidural anesthesia and cancer outcomes in bladder cancer patients: is it the technique or the medication? A matched-cohort analysis from a tertiary referral center.
    Chipollini J; Alford B; Boulware DC; Forget P; Gilbert SM; Lockhart JL; Pow-Sang JM; Sexton WJ; Spiess PE; Poch MA; Patel SY
    BMC Anesthesiol; 2018 Nov; 18(1):157. PubMed ID: 30390636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy.
    Linder BJ; Frank I; Cheville JC; Tollefson MK; Thompson RH; Tarrell RF; Thapa P; Boorjian SA
    Eur Urol; 2013 May; 63(5):839-45. PubMed ID: 23332883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restrictive transfusion in radical cystectomy is safe.
    Syan-Bhanvadia S; Drangsholt S; Shah S; Cai J; Miranda G; Djaladat H; Daneshmand S
    Urol Oncol; 2017 Aug; 35(8):528.e15-528.e21. PubMed ID: 28476526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinoma.
    Rieken M; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Faison T; Lotan Y; Karakiewicz PI; Sun M; Fajkovic H; Babjuk M; Bachmann A; Scherr DS; Shariat SF
    Urol Oncol; 2014 Jan; 32(1):49.e7-14. PubMed ID: 24140245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic impact of perioperative blood transfusion on survival in patients with bladder urothelial carcinoma treated with radical cystectomy.
    Lee JS; Kim HS; Jeong CW; Kwak C; Kim HH; Ku JH
    Korean J Urol; 2015 Apr; 56(4):295-304. PubMed ID: 25874043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perioperative blood transfusion and radical cystectomy: does timing of transfusion affect bladder cancer mortality?
    Abel EJ; Linder BJ; Bauman TM; Bauer RM; Thompson RH; Thapa P; Devon ON; Tarrell RF; Frank I; Jarrard DF; Downs TM; Boorjian SA
    Eur Urol; 2014 Dec; 66(6):1139-47. PubMed ID: 25194909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radical cystectomy for recurrent urothelial carcinoma after prior partial cystectomy: perioperative and oncologic outcomes.
    Mason RJ; Frank I; Bhindi B; Tollefson MK; Thompson RH; Karnes RJ; Tarrell R; Thapa P; Boorjian SA
    World J Urol; 2017 Dec; 35(12):1879-1884. PubMed ID: 28913657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors and oncological outcomes of urethral recurrence in male patients with muscle invasive bladder cancer after radical cystectomy combined with urinary diversion: a propensity score-matched case control study.
    Yao Z; Jiang Y; Zhu X; Wu B; Bai S
    Int J Clin Oncol; 2020 Jul; 25(7):1377-1384. PubMed ID: 32318904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ABO Blood Group and Rhesus Factor Are Not Associated with Outcomes After Radical Cystectomy for Non-metastatic Urothelial Carcinoma of the Bladder.
    D'Andrea D; Moschini M; Soria F; Gust KM; Briganti A; Karakiewicz PI; RouprĂȘt M; Shariat SF
    Anticancer Res; 2017 Oct; 37(10):5747-5753. PubMed ID: 28982896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood Transfusion is Associated with Increased Perioperative Morbidity and Adverse Oncologic Outcomes in Bladder Cancer Patients Receiving Neoadjuvant Chemotherapy and Radical Cystectomy.
    Chalfin HJ; Liu JJ; Gandhi N; Feng Z; Johnson D; Netto GJ; Drake CG; Hahn NM; Schoenberg MP; Trock BJ; Scott AV; Frank SM; Bivalacqua TJ
    Ann Surg Oncol; 2016 Aug; 23(8):2715-22. PubMed ID: 27012987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of preoperative anemia on oncologic outcome in patients undergoing radical cystectomy for urothelial carcinoma of the bladder.
    Jo JK; Jeong SJ; Hong SK; Byun SS; Lee SE; Oh JJ
    Int Urol Nephrol; 2016 Apr; 48(4):489-94. PubMed ID: 26810322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncological long-term outcome of 4772 patients with prostate cancer undergoing radical prostatectomy: does the anaesthetic technique matter?
    Roiss M; Schiffmann J; Tennstedt P; Kessler T; Blanc I; Goetz A; Schlomm T; Graefen M; Reuter DA
    Eur J Surg Oncol; 2014 Dec; 40(12):1686-92. PubMed ID: 24613743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing long-term outcomes of primary and progressive carcinoma invading bladder muscle after radical cystectomy.
    Moschini M; Sharma V; Dell'oglio P; Cucchiara V; Gandaglia G; Cantiello F; Zattoni F; Pellucchi F; Briganti A; Damiano R; Montorsi F; Salonia A; Colombo R
    BJU Int; 2016 Apr; 117(4):604-10. PubMed ID: 25851271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term oncological outcomes in women undergoing radical cystectomy and orthotopic diversion for bladder cancer.
    Stein JP; Penson DF; Lee C; Cai J; Miranda G; Skinner DG
    J Urol; 2009 May; 181(5):2052-8; discussion 2058-9. PubMed ID: 19286213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of perioperative blood transfusion on survival following radical cystectomy for urothelial carcinoma.
    Sadeghi N; Badalato GM; Hruby G; Kates M; McKiernan JM
    Can J Urol; 2012 Oct; 19(5):6443-9. PubMed ID: 23040626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity is associated with worse oncological outcomes in patients treated with radical cystectomy.
    Chromecki TF; Cha EK; Fajkovic H; Rink M; Ehdaie B; Svatek RS; Karakiewicz PI; Lotan Y; Tilki D; Bastian PJ; Daneshmand S; Kassouf W; Durand M; Novara G; Fritsche HM; Burger M; Izawa JI; Brisuda A; Babjuk M; Pummer K; Shariat SF
    BJU Int; 2013 Feb; 111(2):249-55. PubMed ID: 22727036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy.
    Viers BR; Boorjian SA; Frank I; Tarrell RF; Thapa P; Karnes RJ; Thompson RH; Tollefson MK
    Eur Urol; 2014 Dec; 66(6):1157-64. PubMed ID: 24630414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.